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568 Abstracts February 2015cost effectiveness strategies. Clearly, however, there is still no clearly
accepted optimal treatment for intermittent claudication.Metabolic Syndrome Predicts Restenosis After Carotid
Endarterectomy
Williams WT, Assi R, Hall MR, et al. J Am Coll Surg 2014;219:771-7.
Conclusions: Metabolic syndrome is an independent predictor for
restenosis after carotid endarterectomy (CEA).
Summary: In modern studies, restenosis after endarterectomy for
symptomatic severe carotid artery stenosis occurs at a rate of 5% at 3 years
(Arquizan C et al, Stroke 2011;42:1015-20). Other studies suggest that
at 15 years after CEA rates of stroke associated with restenosis may be as
high as 50% (Fluri F et al, Cerebrovasc Dis 2008;26:654-8). Obviously
restenosis after CEA therefore has the potential to lead to additional inter-
ventions and adverse outcomes. Factors predicting restenosis after CEA
however, are poorly understood. The purpose of this study was to examine
which risk factors are potentially associated with restenosis after CEA. This is
a retrospective study that examined the records of all patients who under-
went CEA at the Veterans Affairs Connecticut Healthcare System during
a 4-year period. Metabolic syndrome was deﬁned as the presence of 3 or
more of the following: hypertension as deﬁned by a blood pressure
$130 mmHg; serum triglycerides $150 mg/dl; high-density lipoprotein
$40 mg/dl; BMI $25 kg/m2; and fasting blood glucose$ 10 mg/dl. Ma-
jor adverse events were deﬁned as stroke, death or MI. Restenosis was
deﬁned as >50% stenosis on follow-up imaging studies. There were 78 pa-
tients who underwent 79 CEAs during the study period. All patients were
male and 76% were Caucasian. Mean age was 72.6 years. Mean duration
of follow-up was 5.2 years. 67% of patients had metabolic syndrome. Pa-
tients with metabolic syndrome were comparable with those without meta-
bolic syndrome in demographics and preoperative comorbidities except for
increased hypertension and diabetes, as expected, and in chronic renal insuf-
ﬁciency (P ¼ .05). There was no signiﬁcant difference in long-term survival
or freedom from major adverse events between patients with and without
metabolic syndrome. However, restenosis was signiﬁcantly higher in pa-
tients with metabolic syndrome (P ¼ .02) and occurred 2 years after CEA
in patients with metabolic syndrome only, with a large increase in restenosis
after 5 years (P ¼ .018). In a multivariable analysis metabolic syndrome
remained an independent predictor of restenosis (P ¼ .01).
Comment: Most studies examining the rate of restenosis following
carotid endarterectomy have shorter periods of follow-up than exhibited
here. Although in this small study the authors were unable to demonstrate
a difference in major adverse events in the patients with metabolic syndrome
vs those without metabolic syndrome, an anatomic goal of carotid endarter-
ectomy is to maintain patency of the artery without restenosis. The data
does not allow it to be determined whether control of the individual com-
ponents of the metabolic syndrome around the time of endarterectomy
would reduce late restenosis. It appears patients with metabolic syndrome
at the time of CEA are at risk for restenosis and thus could constitute a
group of patients for whom more frequent and-or long-term surveillance
is warranted. In addition such patients may serve as a target for even
more intensive medical management of the individual components of their
metabolic syndrome at the time of their original operation.Preventable Readmissions to Surgical Services: Lessons
Learned and Targets for Improvement
Dawes AJ, Sacks GD, Russell MM, et al. J Am Coll Surg 2014;219:382-9.
Conclusions: A minority of readmissions may potentially be prevent-
able. Policies aimed at penalizing reimbursements based on readmission
rates should use clinical data to focus on inappropriate hospitalization as a
measure to promote high quality patient care.
Summary: Vascular surgical patients have overall high readmission
rates compared to many other types of patients. As a measure of health
care quality, hospital readmissions are a prominent focus currently. The
Center for Medicare and Medicaid Services (CMS) proposes using readmis-
sion rates as a benchmark to improve care, including targeting them as non-
reimbursable events. The study here was designed to describe potentially
preventable readmissions after surgery and identify targets for improvement.
The study focused on patients discharged from a surgical service over 8
consecutive quarters (Q4 2009 to Q3 2011). A working group of attending
surgeons deﬁned terms and created classiﬁcation schemes. Thirty-day read-
missions were identiﬁed and reviewed by a 2-physician team. Readmissions
were then categorized as unpreventable or preventable, and as targets for
future quality improvement intervention. Overall readmission rate was
8.3% (315 of 3789 admissions). The most common indication for initial
admission was elective surgery. Among admitted patients in the sample,
28% did not undergo an operation during their index admission. Only21% (55 of 258) of readmissions were likely preventable based on medical
record review. Of the preventable readmissions, 38% of patients were dis-
charged within 24 hours and 60 % within 48 hours. Dehydration occurred
more frequently among preventable readmissions (P < .001). Infection
accounted for more than one-third of all readmissions. Preventable readmis-
sions targets for improvement included closer follow-up after discharge
(49%), management of the outpatient setting (42%), and avoidance of pre-
mature discharge (9%).
Comment: It is very likely that the complexity of medical care will
preclude total elimination of readmissions. Many readmissions actually
reﬂect clinically appropriate care delivery and of course some reﬂect unnec-
essary or inappropriate care or discretionary events. This paper is a step in
the right direction in that indicates that treating all readmissions as unavoid-
able events is likely not practical or realistic. Efforts should be geared toward
distinguishing preventable from unpreventable readmissions to promote the
overall goal of delivery of high-quality care.Intraplaque Hemorrhage, Fibrous Cap Status, and
Microembolic Signals in Symptomatic Patients With Mild
to moderate Carotid Artery Stenosis: The Plaque At RISK
Study
Truijman MTB, de Rotte AAJ, Aaslid R, et al. Stroke 2014;45:3423-6.
Conclusions: In patients with symptomatic mild to moderate carotid
artery stenosis, intraplaque hemorrhage (IPH) and the status of the ﬁbrous
cap (FC) are not associated with microbembolic signals (MES) as deter-
mined by transcranial Doppler (TCD). MRI and TCD therefore likely pro-
vide different information on plaque vulnerability.
Summary: The primary way of estimating risk of a carotid artery pla-
que is the degree of stenosis. However, there are other plaque characteristics
that may be important as well. Detection of plaques which are prone to
rupture, so-called vulnerable plaques, may help to determine the best ther-
apeutic approach to patients with carotid stenosis, especially patients with
mild to moderate carotid artery stenosis. In patients with mild to moderate
symptomatic carotid artery stenosis increased risk of stroke or recurrent
stroke has been associated with IPH and a thin/ruptured FC as evaluated
by MRI, and MES detected with TCD. In this study the authors sought
to determine whether the presence of MES differs in patients with and
without IPH and a thin/ruptured FC, vs patients with only a thin/ruptured
FC but without IPH. This is a multicenter, diagnostic cohort study. Patients
(n ¼ 113) with recent transient ischemic attack (TIA) or minor stroke in the
carotid territory and ipsilateral mild to moderate carotid artery plaque were
included. IPH and FC status were dichotomously scored. TCD data was
analyzed blinded to results of MRI. TCD measurements were feasible in
105/113, with an average recording time of 219 minutes. A total of 26
MESs were detected in 8 of 105 patients. In 44 of 105 plaques IPH was
present. In 92 of 105 plaques FC status was assessable and 36 of these
had a thin/ruptured FC. There was no signiﬁcant difference in the preva-
lence of MES between patients with and without IPH (P ¼ .46) or those
with thick vs thin/ruptured FC (P ¼ .48).
Comment: The study differs from a previous study that correlated a
signiﬁcant relationship between MES occurrence and the presence of a
vulnerable plaque on MRI. Patients in that study (Altaf N, et al. Radiology
2011; 258:538-545) had high-grade carotid stenosis compared to mild to
moderate carotid artery stenosis in the patients in the current study. It
maybe, that the mircroembolic potential of a vulnerable plaque is enhanced
by the ﬂow effects induced by high-grade carotid stenosis. One wonders
whether the “vulnerable” plaque in isolation in the carotid circulation is
really all that important and only becomes important when associated
with signiﬁcant stenosis. Longer term data focusing on clinical outcomes
rather than just analysis of MES signals is needed to answer this sort of
question.Long-Term Follow-Up Study of Endarterectomy Versus
Angioplasty in Patients With Symptomatic Severe Carotid
Stenosis Trial
Mas JL, Arquizan C, Calvet D, EVA-3S Investigators. Stroke 2014;45:
2750-6.
Conclusions: The long-term risk-beneﬁt of carotid stenting (CAS) vs
endarterectomy (CEA) for symptomatic carotid stenosis favors CEA and the
difference is driven by lower risk of procedural stroke after CEA compared
to CAS.
Summary: This study presents long-term follow-up of patients
included in the endarterectomy vs angioplasty in patients with symptomatic
severe carotid artery stenosis (EVA-3S) trial. This is a randomized control
trial of CAS vs CEA in 527 patients who had had recently symptomatic se-
vere carotid stenosis. The trial was conducted in 30 centers in France and
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2006;355:1660-71). At that time the authors reported a lower periproce-
dural stroke rate with CEA than with CAS. The current study focuses on
long-term follow-up of the patients and is designed to clarify the durability
of the two procedures with regard to stroke prevention. There was a mean
follow-up of 7.1 years (interquartile range, 5.1-8.8 years; maximum,
12.4 years). The primary endpoint was a composite of any ipsilateral stroke
after randomization or any procedural stroke or death. The primary
endpoint occurred in 30 patients in the stenting group compared with 18
patients in the endarterectomy group. Cumulative probabilities of this
outcome were 11.0% (95% CI, 7.9-15.2) vs 6.3% (4.0-9.8) in the endarter-
ectomy group at the 5-year follow-up point (hazard ratio, 1.85; 1.00-3.40;
P ¼ .04) and 11.5% (8.2-15.9) vs 7.6% (4.9-11.8; hazard ratio, 1.70; 0.95-
3.06; P ¼ .07) at the 10-year follow-up time. There was no difference
observed between treatment groups in the rates of ipsilateral stroke beyond
the procedural period, severe recurrent carotid restenosis ($70%) or occlu-
sion, death, myocardial infarction, and revascularization procedures.
Comment: The study presents long-term information on the dura-
bility of CAS vs CEA in preventing stroke following the periprocedural
period. Previously the CREST investigators have also shown that at 2-years
rates of restenosis following CEA and CAS are similar (Lal BK et al, Lancet
Neurol 2012;11:755-63). Clearly both procedures can be durable. For CAS
to be more widely accepted by both physicians and patients, periprocedural
stroke risk must be brought down to the same level of that as CEA.Meta-Analysis and Meta-Regression Analysis of Biomarkers
for Abdominal Aortic Aneurysm
Stather PW, Sidloff DA, Dattani N, et al. BJS 2014;101:1358-72.
Conclusions: There are many biomarkers that are dysregulated in pa-
tients with abdominal aortic aneurysm (AAA) but their clinical value has yet
to be established.Summary: There have been a number of studies on systemic and
local levels of biomarkers in patients with AAA that have yielded conﬂict-
ing results. Previous meta-analysis in patients with AAA have identiﬁed
increased levels of circulating ﬁbrinogen, D-dimer and thrombin-anti-
thrombin III complex in patients with AAA. In addition there has
been a signiﬁcant correlation between aortic diameter and D-dimer level
(Sidloff D et al, J Vasc Surg 2014; 59:528-35.e4). In addition to these
haematologic markers previously studied there are additional potential
biomarkers related to other processes that involve aneurysm formation.
The aim of the present study therefore was to undertake a systematic re-
view and, when possible, meta-analysis and meta-regression of studies
comparing the clinical value of alternative biomarkers for AAA such as
matrix metalloproteinases (MMPs), inﬂammatory markers, acute-phase
reactants and lipids. The authors reviewed literature from 106 studies.
Meta-analysis demonstrated a signiﬁcant difference between matrix met-
alloproteinases (MMP) 9, tissue inhibitor of MMP 1, interleukin (IL) 6,
C-reactive protein (CRP), a1-antitrypsin, triglycerides, lipoprotein (a),
apolipoprotein A and high-density lipoprotein in patients with and
without AAA. Meta-analysis was not possible for MMP-2 in aortic tissue,
tumor necrosis factor a, osteoprotegerin, osteopontin, interferon g,
intercellular cell adhesion molecule 1 and vascular cell adhesion mole-
cule 1. However, systematic review suggested an increase in these bio-
markers in patients with AAA. Meta-regression analysis also identiﬁed
a linear correlation between aortic diameter and C-reactive protein
(CRP) level.
Comment: The data reﬂect the fact that formation of an AAA is a
complex biochemical event. Biomarkers can potentially be used clinically
in combination with markers of stress and strain on the aneurysm wall to
identify patients at risk for aneurysm rupture and to assess the effects of
medical managements on aneurysm growth and risk of rupture. Hopefully
this will be the focus of future research. It is likely to keep biostatisticians
busy for quite some time.
